Wei Lin
Insider CIK 1872772 · RVMD Chief Medical Officer · ERAS Chief Medical Officer · TSVT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines, Inc. | S Sale | 2026-03-17 | 2026-03-19 | 2,073 | $99.48 | $206.2K | 101,366 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award deriv | 2026-03-01 | 2026-03-03 | 34,000 | — | $0 | 34,000 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award | 2026-03-01 | 2026-03-03 | 15,100 | — | $0 | 103,439 | SEC↗ |
| RVMD Revolution Medicines, Inc. | S Sale | 2025-09-16 | 2025-09-18 | 2,160 | $45.82 | $99.0K | 88,339 | SEC↗ |
| RVMD Revolution Medicines, Inc. | S Sale | 2025-06-16 | 2025-06-18 | 2,173 | $39.83 | $86.6K | 90,499 | SEC↗ |
| TSVT 2seventy bio, Inc. | D To issuer deriv | 2025-05-13 | 2025-05-15 | 24,100 | — | $0 | 0 | SEC↗ |
| TSVT 2seventy bio, Inc. | D To issuer | 2025-05-13 | 2025-05-15 | 17,583 | — | $0 | 15,267 | SEC↗ |
| TSVT 2seventy bio, Inc. | U Tender | 2025-05-13 | 2025-05-15 | 15,267 | — | $0 | 0 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award deriv | 2025-03-01 | 2025-03-04 | 72,800 | — | $0 | 72,800 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award | 2025-03-01 | 2025-03-04 | 20,800 | — | $0 | 91,651 | SEC↗ |
| RVMD Revolution Medicines, Inc. | S Sale | 2024-06-17 | 2024-06-20 | 5,589 | $37.39 | $209.0K | 70,851 | SEC↗ |
| TSVT 2seventy bio, Inc. | A Award deriv | 2024-06-10 | 2024-06-12 | 24,100 | — | $0 | 24,100 | SEC↗ |
| TSVT 2seventy bio, Inc. | A Award | 2024-06-10 | 2024-06-12 | 12,050 | — | $0 | 32,850 | SEC↗ |
| TSVT 2seventy bio, Inc. | A Award deriv | 2023-06-13 | 2023-06-15 | 8,450 | — | $0 | 8,450 | SEC↗ |
| TSVT 2seventy bio, Inc. | A Award | 2023-06-13 | 2023-06-15 | 4,200 | — | $0 | 20,800 | SEC↗ |
| TSVT 2seventy bio, Inc. | A Award deriv | 2023-03-07 | 2023-03-09 | 33,400 | — | $0 | 33,400 | SEC↗ |
| TSVT 2seventy bio, Inc. | A Award | 2023-03-07 | 2023-03-09 | 16,600 | — | $0 | 16,600 | SEC↗ |
| ERAS Erasca, Inc. | A Award deriv | 2023-02-01 | 2023-02-03 | 560,000 | — | $0 | 560,000 | SEC↗ |
| ERAS Erasca, Inc. | J Other | 2023-02-01 | 2023-02-03 | 1,748 | $4.10 | $7.2K | 315,812 | SEC↗ |
| ERAS Erasca, Inc. | J Other | 2023-02-01 | 2023-02-03 | 2 | $3.89 | $8 | 315,812 | SEC↗ |
| ERAS Erasca, Inc. | A Award deriv | 2022-02-01 | 2022-02-03 | 272,100 | — | $0 | 272,100 | SEC↗ |
| ERAS Erasca, Inc. | J Other | 2022-02-01 | 2022-02-03 | 1,562 | $11.60 | $18.1K | 314,062 | SEC↗ |